Wikidata

(Q63840495)

English

Phase 3 Extension Study of Dexpramipexole in ALS

clinical trial

In more languages

Statements

short name
ENVISION (English)
0 references
title
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis (English)
0 references
country
Australia
0 references
Belgium
0 references
Canada
0 references
France
0 references
Germany
0 references
Republic of Ireland
0 references
Netherlands
0 references
Spain
0 references
Sweden
0 references
United Kingdom
0 references
start time
June 2012
0 references
end time
February 2013
0 references
number of participants
616
0 references
research site
Emory University
0 references
Columbia University
0 references
Wake Forest University
0 references
Ohio State University
0 references
Texas Neurology
0 references
University of Virginia
0 references
McGill University
0 references
Utrecht University
0 references
Hospital Carlos III
0 references
Karolinska Institutet
0 references
Dartmouth University
0 references
Drexel University
0 references
Westmead Hospital
0 references
minimum age
18 year
0 references
maximum age
80 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63840495&oldid=1857493184"